By Mill Chart
Last update: Feb 21, 2025
Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if HIMS & HERS HEALTH INC (NYSE:HIMS) is suited for growth investing. Investors should of course do their own research, but we spotted HIMS & HERS HEALTH INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
ChartMill assigns a Fundamental Rating to every stock. This score, ranging from 0 to 10, is updated daily and is determined by evaluating multiple fundamental indicators and properties.
We assign a fundamental rating of 5 out of 10 to HIMS. HIMS was compared to 108 industry peers in the Health Care Providers & Services industry. HIMS has an excellent financial health rating, but there are some minor concerns on its profitability. HIMS is quite expensive at the moment. It does show a decent growth rate.
Check the latest full fundamental report of HIMS for a complete fundamental analysis.
Our Lois Navellier screen will find you more ideas suited for growth investing.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
51.96
+0.56 (+1.09%)
Find more stocks in the Stock Screener
Wall Street Retreats as Pharma Stocks Tumble and Trade Uncertainty Lingers
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
Get a pulse on the US markets on Tuesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
Let's have a look at the gap up and gap down stocks in today's session.
Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.